Related Experiment Video
Updated: Aug 8, 2025

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.3K
The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane
Hae Lin Cho1, Subha Perni2, Anthony V D'Amico3
1Harvard Medical School, Boston, MA, USA. haelin_cho@hms.harvard.edu.
Prostate Cancer and Prostatic Diseases
|March 5, 2023
Abstract
No abstract available in PubMed .

